Friday, 9 October 2026European Markets

RENAULT And EXOR NV Have A High Dividend Yield And Return On Equity In The Auto Manufacturers Industry.

Loading stream...

(vianews) - renault (rno.pa) is among this list of stock assets with the highest dividend rate and return on equity on the auto manufacturers industry.

financial asset price forward dividend yield return on equity
renault (rno.pa) €32.79 0.76% 5.64%
exor nv (exo.as) €76.06 0.59% 17.9%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. renault (rno.pa)

0.76% forward dividend yield and 5.64% return on equity

renault sa engages in the design, manufacture, sale, repair, maintenance, and leasing of motor vehicles in europe, eurasia, africa, the middle east, the asia pacific, and the americas. it also engages in the design and production of parts and equipment used for manufacturing and operating vehicles. the company operates through automotive, sale financing, and mobility services segments. its automotive segment produces, sells, and distributes passenger cars and light commercial vehicles; and invests in automotive-sector associates and joint ventures primarily in nissan. the company's sale financing segment offers sale financing, leasing, maintenance, and services contract under the mobilize financial services brand. its mobility services segment provides mobility and energy solutions for electric vehicle users under the mobilize brand. in addition, it is also involved in the design, manufacture, and sale of passenger cars and light commercial vehicles and innovative services under the renault, dacia, alpine, and mobilize brands. further, the company offers used vehicles and spare parts; and engages in business to business powertrain activities, including exchange of powertrain parts and related engineering activities. renault sa was founded in 1898 and is based in boulogne-billancourt, france.

earnings per share

as for profitability, renault has a trailing twelve months eps of €6.07.

pe ratio

renault has a trailing twelve months price to earnings ratio of 5.4. meaning, the purchaser of the share is investing €5.4 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.64%.

more news about renault.

2. exor nv (exo.as)

0.59% forward dividend yield and 17.9% return on equity

exor n.v., together with its subsidiaries, engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide. the company designs, engineers, produces, and sells luxury performance sports cars under the ferrari brand. it also offers automotive vehicles and mobility solutions under the abarth, alfa romeo, chrysler, citroen, dodge, ds, fiat, fiat professional, jeep, lancia, maserati, mopar, opel, peugeot, ram, and vauxhall brands; and retail and dealer financing, and rental services for the automotive sector, as well as sells service parts. in addition, the company designs, produces, markets, sells, and finances agricultural and construction equipment, trucks, commercial vehicles, buses, engines, and car spare parts. further, it manages professional football teams under the juventus football club name; publishes the economist, il secolo xix, la repubblica and la stampa, and other newspapers and magazines; offers digital and advertising, and conference and electronic services; and operates three national radio stations, including radio deejay. additionally, the company provides furniture, homeware, apparel, leather goods, jewelry, and accessories; and offers footwear. the company was founded in 1899 and is headquartered in amsterdam, the netherlands. exor n.v. is a subsidiary of giovanni agnelli b.v.

earnings per share

as for profitability, exor nv has a trailing twelve months eps of €12.22.

pe ratio

exor nv has a trailing twelve months price to earnings ratio of 6.22. meaning, the purchaser of the share is investing €6.22 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.9%.

more news about exor nv.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,362 source documents archived
Query this data → isubstrate.com